VP-2b, a major structural protein of infectious bursal disease virus (IBDV), and its precursor protein VP-2a were separated in a soluble form from the supernatant of ultracentrifuged viruses by using a monoclonal antibody specific for VP-3, the other major structural protein, to remove soluble VP-3 and remaining virus particles. The native VP-2a/2b inhibited the majority of virus-neutralizing (VN) activity in chicken anti-IBDV sera and chickens immunized with VP-2a/2b produced VN antibodies that passively protected susceptible chickens from infection. However, the separated VP2a/2b was not as immunogenic as intact virus particles. VP-2a/2b would appear to contain a conformational epitope which is destroyed by SDS and boiling and which may prove to be of critical importance in a subunit vaccine against type 1 IBDV,
AzadA. A.,
JagadishM. N.,
BrownM. A.,
HudsonP. J.1987; Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 161:145–152
BechtH.,
MüllerH.,
MüllerH. K.1988; Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. Journal of General Virology 69:631–640
BittleJ. L.,
HoughtenR. A.,
AlexanderH.,
ShinnickT. M.,
SutcliffeJ. G.,
LernerR. A.,
RowlandsD. J.,
BrownF.1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
BurnetteW. N.1981; “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Analytical Biochemistry 112:195–203
CohenG. H.,
DietzscholdB.,
Ponce De LeonM.,
LongD.,
GolubE.,
VarrichioA.,
PereiraL.,
EisenbergR. J.1984; Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. Journal of Virology 49:102–108
CohenG. H.,
IsolaV. J.,
KuhnsJ.,
BermanP. W.,
EisenbergR. J.1986; Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing (“native” gel) system of polyacrylamide gel electrophoresis coupled with Western blotting. Journal of Virology 60:157–166
Dyall-SmithM. L.,
LazdinsI.,
TregearG. W.,
HolmesI. H.1986; Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proceedings of the National Academy of Sciences, U.S.A 83:3465–3468
FaheyK. J.,
O’donnellI. J.,
AzadA. A.1985a; Characterization by Western blotting of the immunogens of infectious bursal disease virus. Journal of General Virology 66:1479–1488
FaheyK. J.,
O’donnellI. J.,
BagustT. J.1985b; Antibody to the 32K structural protein of infectious bursal disease virus neutralizes viral infectivity in vitro and confers protection on young chickens. Journal of General Virology 66:2693–2702
HudsonP. J.,
MckernN. M.,
PowerB. E.,
AzadA. A.1986; Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Research 14:5001–5012
LowryO. H.,
RosebroughN. J.,
FarrA. L.,
RandallR. J.1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
MüllerH.,
BechtH.1982; Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles. Journal of Virology 44:384–392
SamsonA. C. R.,
WillcocksM. M.,
RoutledgeE. G.,
MorganL. A.,
TomsG. L.1986; A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein. Journal of General Virology 67:1479–1483